tiprankstipranks
Advertisement
Advertisement

Apiam Animal Health Issues 1.56 Million New Shares on Option Conversions

Story Highlights
  • Apiam Animal Health operates veterinary and animal health services, focusing on livestock and regional markets in Australia.
  • The company issued 1,560,203 new ordinary shares on 6 February 2026 from exercised unquoted options, slightly increasing share capital and diluting existing holders.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Apiam Animal Health Issues 1.56 Million New Shares on Option Conversions

Meet Samuel – Your Personal Investing Prophet

Apiam Animal Health Ltd. ( (AU:AHX) ) has issued an update.

Apiam Animal Health Ltd has announced the issue of 1,560,203 new fully paid ordinary shares following the exercise or conversion of previously unquoted options or other convertible securities. The issuance, dated 6 February 2026, modestly increases the company’s share capital and reflects the uptake of equity-based instruments, which may slightly dilute existing shareholders while signalling ongoing engagement with long-term incentive structures within the business.

The most recent analyst rating on (AU:AHX) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Apiam Animal Health Ltd. stock, see the AU:AHX Stock Forecast page.

More about Apiam Animal Health Ltd.

Apiam Animal Health Ltd is an ASX-listed veterinary and animal health company operating in Australia, providing veterinary services and related animal health products, with a focus on livestock and production animals as well as companion animals across regional and rural markets.

Average Trading Volume: 278,174

Technical Sentiment Signal: Buy

Current Market Cap: A$160.1M

Learn more about AHX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1